{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:56:03Z","timestamp":1790826963407,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","transplantation-proceedings.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.transproceed.2017.07.001","type":"journal-article","created":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T20:49:15Z","timestamp":1505767755000},"page":"1766-1772","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience"],"prefix":"10.1016","volume":"49","author":[{"given":"E.","family":"Favi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Santangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Iesari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Morandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.E.","family":"Marcovecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.M.","family":"Trecarichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.P.","family":"Salerno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ferraresso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Citterio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Romagnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.transproceed.2017.07.001_bib1","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.2165\/11319260-000000000-00000","article-title":"Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection","volume":"69","author":"Marcen","year":"2009","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.transproceed.2017.07.001_bib2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s11908-012-0292-2","article-title":"Cytomegalovirus in solid organ transplantation: epidemiology, prevention, and treatment","volume":"14","author":"Beam","year":"2012","journal-title":"Curr Infect Dis Rep"},{"issue":"3","key":"10.1016\/j.transproceed.2017.07.001_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1399-3062.2009.00372.x","article-title":"Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation","volume":"11","author":"Fisher","year":"2009","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"10.1016\/j.transproceed.2017.07.001_bib4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1399-0012.2006.00618.x","article-title":"Cytomegalovirus in transplantation - challenging the status quo","volume":"21","author":"Fishman","year":"2007","journal-title":"Clin Transplant"},{"issue":"5","key":"10.1016\/j.transproceed.2017.07.001_bib5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/rmv.513","article-title":"Antiviral drugs for cytomegalovirus in transplant recipients: advantages of preemptive therapy","volume":"16","author":"Singh","year":"2006","journal-title":"Rev Med Virol"},{"issue":"2","key":"10.1016\/j.transproceed.2017.07.001_bib6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/01.tp.0000183970.71366.da","article-title":"Preemptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients","volume":"81","author":"Strippoli","year":"2006","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.transproceed.2017.07.001_bib7","first-page":"10","article-title":"A\u00a0systematic review and meta-analysis of prophylactic versus pre-emptive strategies for preventing cytomegalovirus infection in renal transplant recipients","volume":"3","author":"Rawal","year":"2012","journal-title":"Int J Organ Transplant Med"},{"key":"10.1016\/j.transproceed.2017.07.001_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jcv.2007.12.001","article-title":"Monitoring human cytomegalovirus infection in transplant recipients","volume":"41","author":"Baldanti","year":"2008","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.transproceed.2017.07.001_bib9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0b013e31829df29d","article-title":"Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"96","author":"Kotton","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2017.07.001_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0022-1759(83)90308-3","article-title":"A\u00a0solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells","volume":"65","author":"Czerkinsky","year":"1983","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.transproceed.2017.07.001_bib11","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ymeth.2005.11.006","article-title":"Measurement of cytokine release at the single cell level using the ELISPOT assay","volume":"38","author":"Cox","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.transproceed.2017.07.001_bib12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1046-2023(03)00124-5","article-title":"Quantification and characterization of specific T-cells by antigen-specific cytokine production using ELISPOT assay or intracellular cytokine staining","volume":"31","author":"Letsch","year":"2003","journal-title":"Methods"},{"key":"10.1016\/j.transproceed.2017.07.001_bib13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.transproceed.2009.12.030","article-title":"Monitoring cytomegalovirus T-cell immunity in small bowel\/multivisceral transplant recipients","volume":"42","author":"Chiereghin","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2017.07.001_bib14","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.transproceed.2011.03.024","article-title":"Evaluation and significance of cytomegalovirus-specific cellular immune response in lung transplant recipients","volume":"43","author":"Costa","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2017.07.001_bib15","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/tri.12318","article-title":"Human CMV-specific T-cell responses in kidney transplantation; toward changing current risk-stratification paradigm","volume":"27","author":"Lucia","year":"2014","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2017.07.001_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-61779-325-7_1","article-title":"Unique strengths of ELISPOT for T cell diagnostics","volume":"792","author":"Lehmann","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.transproceed.2017.07.001_bib17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/cells4010056","article-title":"ELISPOTs produced by CD8 and CD4 cells follow log normal size distribution permitting objective counting","volume":"4","author":"Karulin","year":"2015","journal-title":"Cells"},{"key":"10.1016\/j.transproceed.2017.07.001_bib18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/tid.12509","article-title":"Early cytomegalovirus-specific T-cell response and estimated glomerular filtration rate identify patients at high risk of infection after renal transplantation","volume":"18","author":"Leone","year":"2016","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transproceed.2017.07.001_bib19","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1086\/654931","volume":"202","author":"Abate","year":"2010","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.transproceed.2017.07.001_bib20","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1128\/JCM.06406-11","article-title":"Human cytomegalovirus-specific T-cell immune reconstitution in preemptively treated heart transplant recipients identifies subjects at critical risk for infection","volume":"50","author":"Abate","year":"2012","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.transproceed.2017.07.001_bib21","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1517\/14656566.2010.492395","article-title":"Strategies for managing cytomegalovirus in transplant recipients","volume":"11","author":"Razonable","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.transproceed.2017.07.001_bib22","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1086\/591532","article-title":"Impact of current transplantation management on the development of cytomegalovirus disease after renal transplantation","volume":"47","author":"San Juan","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transproceed.2017.07.001_bib23","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/tid.12601","article-title":"Role of mTOR inhibitors for the control of viral infection in solid organ transplant recipients","volume":"18","author":"Pascual","year":"2016","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transproceed.2017.07.001_bib24","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.trim.2008.11.002","article-title":"High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function","volume":"20","author":"Nickel","year":"2009","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.transproceed.2017.07.001_bib25","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/ajt.12256","article-title":"Pretransplant immediately early-1-specific T cell responses provide protection for CMV infection after kidney transplantation","volume":"13","author":"Bestard","year":"2013","journal-title":"Am J Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134517305560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134517305560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T11:38:28Z","timestamp":1535369908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134517305560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0041134517305560"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2017.07.001","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2017.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}